SMAD3 regulates gonadal tumorigenesis

Qinglei Li, Jonathan M. Graff, Anne E. O'Connor, Kate L. Loveland, Martin M. Matzuk

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Inhibin is a secreted tumor suppressor and an activin antagonist. Inhibin α null mice develop gonadal sex cord-stromal tumors with 100% penetrance and die of a cachexia-like syndrome due to increased activin signaling. Because Sma and Mad-related protein (SMAD)2 and SMAD3 transduce activin signals in vitro, we attempted to define the role of SMAD3 in gonadal tumorigenesis and the wasting syndrome by generating inhibin α and Smad3 double mutant mice. Inhibin α and Smad3 double homozygous males were protected from early tumorigenesis and the usual weight loss and death. Approximately 90% of these males survived to 26 wk in contrast to 95% of inhibin-deficient males, which develop bilateral testicular tumors and die of the wasting syndrome by 12 wk. Testicular tumors were either absent or unilaterally slow growing and less hemorrhagic in the majority of double-knockout males. In contrast, development of the ovarian tumors and wasting syndrome was delayed, but still occurred, in the majority of the double-knockout females by 26 wk. In double mutant females, tumor development was accompanied by typical activin-induced pathological changes. In summary, we identify an important function of SMAD3 in gonadal tumorigenesis in both sexes. However, this effect is significantly more pronounced in the male, indicating that SMAD3 is the primary transducer of male gonadal tumorigenesis, whereas SMAD3 potentially overlaps with SMAD2 function in the ovary. Moreover, the activin-induced cachexia syndrome is potentially mediated through both SMAD2 and SMAD3 or only through SMAD2 in the liver and stomach. These studies identify sexually dimorphic functions of SMAD3 in gonadal tumorigenesis.

Original languageEnglish (US)
Pages (from-to)2472-2486
Number of pages15
JournalMolecular Endocrinology
Volume21
Issue number10
DOIs
StatePublished - Oct 2007

Fingerprint

Activins
Inhibins
Carcinogenesis
Wasting Syndrome
Cachexia
Testicular Neoplasms
Sex Cord-Gonadal Stromal Tumors
Smad Proteins
Neoplasms
Penetrance
Transducers
Weight Loss
Ovary
Stomach
Liver

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism

Cite this

Li, Q., Graff, J. M., O'Connor, A. E., Loveland, K. L., & Matzuk, M. M. (2007). SMAD3 regulates gonadal tumorigenesis. Molecular Endocrinology, 21(10), 2472-2486. https://doi.org/10.1210/me.2007-0147

SMAD3 regulates gonadal tumorigenesis. / Li, Qinglei; Graff, Jonathan M.; O'Connor, Anne E.; Loveland, Kate L.; Matzuk, Martin M.

In: Molecular Endocrinology, Vol. 21, No. 10, 10.2007, p. 2472-2486.

Research output: Contribution to journalArticle

Li, Q, Graff, JM, O'Connor, AE, Loveland, KL & Matzuk, MM 2007, 'SMAD3 regulates gonadal tumorigenesis', Molecular Endocrinology, vol. 21, no. 10, pp. 2472-2486. https://doi.org/10.1210/me.2007-0147
Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM. SMAD3 regulates gonadal tumorigenesis. Molecular Endocrinology. 2007 Oct;21(10):2472-2486. https://doi.org/10.1210/me.2007-0147
Li, Qinglei ; Graff, Jonathan M. ; O'Connor, Anne E. ; Loveland, Kate L. ; Matzuk, Martin M. / SMAD3 regulates gonadal tumorigenesis. In: Molecular Endocrinology. 2007 ; Vol. 21, No. 10. pp. 2472-2486.
@article{442e42433b21492db46f913e461b3ce2,
title = "SMAD3 regulates gonadal tumorigenesis",
abstract = "Inhibin is a secreted tumor suppressor and an activin antagonist. Inhibin α null mice develop gonadal sex cord-stromal tumors with 100{\%} penetrance and die of a cachexia-like syndrome due to increased activin signaling. Because Sma and Mad-related protein (SMAD)2 and SMAD3 transduce activin signals in vitro, we attempted to define the role of SMAD3 in gonadal tumorigenesis and the wasting syndrome by generating inhibin α and Smad3 double mutant mice. Inhibin α and Smad3 double homozygous males were protected from early tumorigenesis and the usual weight loss and death. Approximately 90{\%} of these males survived to 26 wk in contrast to 95{\%} of inhibin-deficient males, which develop bilateral testicular tumors and die of the wasting syndrome by 12 wk. Testicular tumors were either absent or unilaterally slow growing and less hemorrhagic in the majority of double-knockout males. In contrast, development of the ovarian tumors and wasting syndrome was delayed, but still occurred, in the majority of the double-knockout females by 26 wk. In double mutant females, tumor development was accompanied by typical activin-induced pathological changes. In summary, we identify an important function of SMAD3 in gonadal tumorigenesis in both sexes. However, this effect is significantly more pronounced in the male, indicating that SMAD3 is the primary transducer of male gonadal tumorigenesis, whereas SMAD3 potentially overlaps with SMAD2 function in the ovary. Moreover, the activin-induced cachexia syndrome is potentially mediated through both SMAD2 and SMAD3 or only through SMAD2 in the liver and stomach. These studies identify sexually dimorphic functions of SMAD3 in gonadal tumorigenesis.",
author = "Qinglei Li and Graff, {Jonathan M.} and O'Connor, {Anne E.} and Loveland, {Kate L.} and Matzuk, {Martin M.}",
year = "2007",
month = "10",
doi = "10.1210/me.2007-0147",
language = "English (US)",
volume = "21",
pages = "2472--2486",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - SMAD3 regulates gonadal tumorigenesis

AU - Li, Qinglei

AU - Graff, Jonathan M.

AU - O'Connor, Anne E.

AU - Loveland, Kate L.

AU - Matzuk, Martin M.

PY - 2007/10

Y1 - 2007/10

N2 - Inhibin is a secreted tumor suppressor and an activin antagonist. Inhibin α null mice develop gonadal sex cord-stromal tumors with 100% penetrance and die of a cachexia-like syndrome due to increased activin signaling. Because Sma and Mad-related protein (SMAD)2 and SMAD3 transduce activin signals in vitro, we attempted to define the role of SMAD3 in gonadal tumorigenesis and the wasting syndrome by generating inhibin α and Smad3 double mutant mice. Inhibin α and Smad3 double homozygous males were protected from early tumorigenesis and the usual weight loss and death. Approximately 90% of these males survived to 26 wk in contrast to 95% of inhibin-deficient males, which develop bilateral testicular tumors and die of the wasting syndrome by 12 wk. Testicular tumors were either absent or unilaterally slow growing and less hemorrhagic in the majority of double-knockout males. In contrast, development of the ovarian tumors and wasting syndrome was delayed, but still occurred, in the majority of the double-knockout females by 26 wk. In double mutant females, tumor development was accompanied by typical activin-induced pathological changes. In summary, we identify an important function of SMAD3 in gonadal tumorigenesis in both sexes. However, this effect is significantly more pronounced in the male, indicating that SMAD3 is the primary transducer of male gonadal tumorigenesis, whereas SMAD3 potentially overlaps with SMAD2 function in the ovary. Moreover, the activin-induced cachexia syndrome is potentially mediated through both SMAD2 and SMAD3 or only through SMAD2 in the liver and stomach. These studies identify sexually dimorphic functions of SMAD3 in gonadal tumorigenesis.

AB - Inhibin is a secreted tumor suppressor and an activin antagonist. Inhibin α null mice develop gonadal sex cord-stromal tumors with 100% penetrance and die of a cachexia-like syndrome due to increased activin signaling. Because Sma and Mad-related protein (SMAD)2 and SMAD3 transduce activin signals in vitro, we attempted to define the role of SMAD3 in gonadal tumorigenesis and the wasting syndrome by generating inhibin α and Smad3 double mutant mice. Inhibin α and Smad3 double homozygous males were protected from early tumorigenesis and the usual weight loss and death. Approximately 90% of these males survived to 26 wk in contrast to 95% of inhibin-deficient males, which develop bilateral testicular tumors and die of the wasting syndrome by 12 wk. Testicular tumors were either absent or unilaterally slow growing and less hemorrhagic in the majority of double-knockout males. In contrast, development of the ovarian tumors and wasting syndrome was delayed, but still occurred, in the majority of the double-knockout females by 26 wk. In double mutant females, tumor development was accompanied by typical activin-induced pathological changes. In summary, we identify an important function of SMAD3 in gonadal tumorigenesis in both sexes. However, this effect is significantly more pronounced in the male, indicating that SMAD3 is the primary transducer of male gonadal tumorigenesis, whereas SMAD3 potentially overlaps with SMAD2 function in the ovary. Moreover, the activin-induced cachexia syndrome is potentially mediated through both SMAD2 and SMAD3 or only through SMAD2 in the liver and stomach. These studies identify sexually dimorphic functions of SMAD3 in gonadal tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=34548386862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548386862&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0147

DO - 10.1210/me.2007-0147

M3 - Article

C2 - 17595316

AN - SCOPUS:34548386862

VL - 21

SP - 2472

EP - 2486

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 10

ER -